Liver Disease Clinical Trials

Showing 1-20 of 690 trials

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

NCT02968810

This phase II trial studies how well simvastatin works in preventing liver cancer in patients with liver cirrhosis. Simvastatin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

CirrhosisHepatocellular Carcinoma

National Cancer Institute (NCI)52 participantsStarted Jun 2017

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +2 more locations

RECRUITINGNA

EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis.

NCT05597488

The aim of the current study is to assess if EUS-PPGM could predict the treatment response and outcomes of varices to endoscopic variceal ligation (EVL) in patients with chronic hepatitis. The hypothesis is that a high EUS-PPGM value at 3 months correlates with the presence of varices requiring EVL in patients that have received primary or secondary variceal prophylaxis on 1 year follow-up upper endoscopy.

Cirrhosis Portal

Chinese University of Hong Kong160 participantsStarted Nov 2022

Hong Kong, Hong Kong, China

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis.

Related Searches

Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry

Peer Support for Liver Transplant Recipients With History of ALD

The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

LSM and SSM for the Diagnosis of CSPH: a Prospective Cohort Study

Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease

Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis.

Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis

Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis

Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

Spleen Stiffness Measurement for the Detection of Advanced Fibrosis

Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis

Identification of Liver Fibrosis Biomarkers

Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH

Examining the Effects of Different Resistive Exercise Programs in Individuals With Compensated Liver Cirrhosis

Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension